Julien Fourcade Selected Research

Julien Fourcade Research Topics

11	Neoplasms (Cancer) 01/2018 - 08/2006
11	Melanoma (Melanoma, Malignant) 05/2015 - 08/2006
1	Human Influenza (Influenza) 05/2009

6	Neoplasm Antigens (Tumor Antigens)IBA 05/2015 - 10/2008
4	VaccinesIBA 02/2014 - 10/2008
4	EpitopesIBA 02/2012 - 08/2006
4	Peptides (Polypeptides)IBA 01/2011 - 08/2006
3	Immune Checkpoint InhibitorsIBA 01/2018 - 09/2010
3	Immunodominant EpitopesIBA 01/2011 - 08/2006
2	LigandsIBA 05/2015 - 05/2013
2	Interleukin-10 (Interleukin 10)IBA 04/2015 - 05/2013
2	Cancer VaccinesIBA 02/2014 - 08/2006
2	CytokinesIBA 05/2013 - 05/2009
2	HLA-DR Antigens (HLA-DR)IBA 12/2007 - 08/2006
1	Programmed Cell Death 1 ReceptorIBA 05/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2013
1	CTLA-4 AntigenIBA 05/2013
1	Amino Acids FDA Link 05/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2013
1	Tumor Viral Antigens (Large T Antigen)IBA 05/2013
1	EnzymesIBA 05/2013
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Interleukin-2 (IL2)IBA 09/2010
1	AntigensIBA 09/2010
1	MART-1 AntigenIBA 05/2009
1	B7-H1 AntigenIBA 05/2009
1	Monatide (IMS 3015)IBA 10/2008
1	ProMune (CpG 7909)IBA 10/2008
1	mannide monooleateIBA 10/2008
1	HLA-DP Antigens (HLA-DP)IBA 12/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2006

3	Therapeutics 04/2015 - 02/2012
2	Immunotherapy 01/2018 - 12/2007